Demeclocycline

Demeclocycline

Error creating thumbnail:

Demeclocycline 3D ball

Demeclocycline is a semisynthetic derivative of the tetracycline antibiotic group. Originating from the bacterium Streptococcus aureofaciens, demeclocycline possesses dual therapeutic roles: not only as an antibiotic against various infections but also, intriguingly, as an inhibitor of arginine vasopressin. This unique mechanism has led to its utilization in treating hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Clinical Utility and Indications

Demeclocycline has traditionally been employed in the management of mild-to-moderate bacterial infections, leveraging its broad-spectrum antibiotic properties against an array of susceptible pathogens. However, its unconventional application in countering hyponatremia and SIADH—conditions that arise due to aberrant antidiuretic hormone activity—has gained recognition in recent times, albeit as an off-label use.

Mechanistic Insight

The precise mechanism by which demeclocycline operates in SIADH remains elusive. However, prevailing theories postulate that it impedes the binding of arginine vasopressin (commonly known as ADH) to its respective receptor. Through this interference, demeclocycline effectively inhibits antidiuretic hormone activity, leading to augmented free water secretion without simultaneous sodium loss. The resultant effect is an aquaresis—a type of diuresis where water is lost from the body without electrolyte loss—and an elevation in serum sodium levels.

Dosage, Administration, and Safety Profile

Dosage and Administration: Demeclocycline is generally prescribed at doses ranging from 600 mg to 1200 mg daily, split into two to four administrations. It's available in tablet form, typically in concentrations of 150 mg or 300 mg, and can be found commercially under the brand name 'Declomycin'.

Adverse Effects: Like most medications, demeclocycline is not devoid of side effects. Users may experience common adverse reactions such as indigestion, nausea, diarrhea, headache, dizziness, glossitis (inflammation or infection of the tongue), and skin rashes.

Hepatic Implications and Liver Safety

Though specific liver injuries attributed to demeclocycline have been sparse in the medical literature, it's crucial to note its classification as an orally ingested semisynthetic tetracycline. This categorization hints at a potential liver injury profile akin to its relatives like tetracycline, oxytetracycline, and doxycycline. Given its limited use compared to these counterparts, the complete spectrum of hepatic effects triggered by demeclocycline might yet be undiscovered.

See Also

• Tetracycline antibiotics
• Antidiuretic hormone (ADH)
• Hyponatremia

References

List of tetracyclines

• Demeclocycline
• Doxycycline
• Minocycline
• Tetracycline
• Tigecycline

• Dailymed label info on Demeclocycline
• FDA Demeclocycline

Demeclocycline Resources
Latest articles Most recent articles Ongoing trials	Wikipedia